Production as a Service in Pharmaceutical Environment

Synopsis

Manufacturing pharmaceuticals remains resource intensive and supply chains are increasingly affected by investment risks. To reply to this uncertainty while allowing manufacturers to access new machinery, performance oriented payment models are growing in relevance in the manufacturing world: As-a-service concepts enable manufacturers to pay for the outcome of the necessary production equipment, instead for the equipment itself. External investors own the assets and sell production output to one or multiple tenants. The foundation for these business models are IoT ready production lines. HAHN together with its partner FlexFactory are working on PoC for pharmaceutical manufacturing centered around advanced automation capabilities.